Citicoline antagonizes bromazepam-induced amnesia in rats
✍ Scribed by X. Antón Alvarez; Begoña Vecino; Juan Enrique Perea; Danilo Daniele; Ramón Cacabelos
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 175 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
Citicoline is an endogenous intermediate in the biosynthesis of brain phospholipids and acetylcholine used for the treatment of neurodegenerative processes associated with head trauma, stroke, brain aging, cerebrovascular pathology and Alzheimer's disease. In this study we have investigated the eects of citicoline on acquisition and retention in passive avoidance and spatial discriminative learning tasks in control rats and in bomazepam-treated animals. Interactions of citicoline with bromazepam on exploratory behaviour (anxiolytic/sedative activity) and motor co-ordination (myorelaxing activity) were also evaluated to test the speci®city of the cognitive eects of citicoline. Our results indicate that citicoline reverses bromazepam-induced amnesia, improves retention in control rats, and has no signi®cant eects on spontaneous activity and motor co-ordination when given alone or in combination with bromazepam. According to these results we conclude that citicoline acts as a promnesic and anti-amnesic drug with no sedative-myorelaxing activity in rats. Therefore, this compound might be of use for the speci®c treatment of cognitive impairments associated with the chronic use of benzodiazepines.
📜 SIMILAR VOLUMES
## Abstract Mature (10‐month‐old) and aged (25‐month‐old) rats were trained on a passive avoidance task. Following training, rats in each age group were exposed to a hypothermia treatment, restraint alone, or no treatment. The hypothermia treatment involved immersing the mature rats in 4°C water fo
The effects of Fructus Schisandrae (Schizandra Chinensis, (FS) on cycloheximide (CXM)-induced amnesia by using a passive avoidance task were studied in rats. FS at 0.25 and 0.75 g/kg administered for 1 week significantly prolonged the CXM-shortened step-through latency (STL). Of the fractions (n-hex